CM Maryam suspends Multan Nishtar Hospital MS, doctors over spread of HIV
MULTAN: Punjab Chief Minister Maryam Nawaz took decisive action on Saturday, suspending the Medical Superintendent, along with several doctors and the head nurse of Nishtar Hospital, Multan, following reports of HIV transmission during dialysis procedures at the facility. During her visit to the hospital, the chief minister highlighted the need
AIDS outbreak hits Multan’s Nishtar Hospital due to dialysis cross-contamination
MULTAN: In Multan’s Nishtar Hospital, 30 patients have been diagnosed with HIV (Human immunodeficiency viruses) following an outbreak linked to a dialysis procedure, according to hospital officials. The incident reportedly occurred after an HIV-positive patient received dialysis at the hospital’s dialysis unit. Following this, other patients who used the same
Ferozsons teams up with Gilead to manufacture HIV drug in Pakistan
Ferozsons Laboratories Limited (PSX: FEROZ) has secured a non-exclusive voluntary license agreement with Gilead Sciences Ireland UC, allowing it to manufacture and sell generic versions of the HIV drug lenacapavir. The partnership aims to provide high-quality, affordable HIV treatment in resource-constrained, high-burden countries across the developing world. Ferozsons is one
25 Clinics sealed for spreading Hepatitis, HIV in Islamabad
The Islamabad Healthcare Regulatory Authority (IHRA) has sealed 25 clinics in Islamabad over the past week due to unsafe medical practices that contributed to infections like Hepatitis B, C, and HIV, as well as Antimicrobial Resistance (AMR).
UK infected blood scandal & its global reverberations
The UK infected blood scandal, deemed the most catastrophic treatment disaster in the history of the National Health Service (NHS), has left a profound and enduring impact. Between the 1970s and 1990s, nearly 30,000 individuals in the UK contracted HIV or hepatitis as a result of blood transfusions tainted with
New PrEP trial shows no HIV infections
UGANDA: In a groundbreaking development for HIV prevention, Gilead Sciences reported 100 per cent efficacy of its innovative anti-HIV drug, lenacapavir, in the PURPOSE 1 study. Conducted among 2,134 young women and adolescent girls in South Africa and Uganda, the trial revealed zero HIV infections among participants who received twice-yearly
29 children under age of three test positive for HIV in Sindh
At least 29 children under the age of three have tested positive for HIV in the Mirpurkhas district of Sindh, a deeply concerning revelation. According to a doctor, the actual number of cases is likely higher than reported. This alarming situation was detailed in a letter dated June 13 from
